Pediatric antidepressant use drops 23%
The number of patients under 18 on antidepressant drugs dropped by 23% in the first two quarters of 2004, Medco reports. The drop in antidepressant use "contrasts sharply to the steady quarterly chartings of the data since 2002," Medco said. The decline in pediatric use of the drugs coincides with FDA health advisories and increased public attention to potential suicidal tendencies associated with the drugs, Medco notes. An FDA analysis of IMS data presented at its Sept. 13-14 meeting on antidepressant suicidality found no decline in new prescriptions for pediatric patients in the first half of 2004...
You may also be interested in...
Court finds US FDA did not impede Catalyst orphan exclusivity for Firdapse as it approved different indication for competing product. Biogen loses 10-year patent battle against competing multiple sclerosis drug makers.
Cover Three Nutritional Brain Defense marketer agrees to pull claims suggesting the supplement beverage can protect against traumatic brain injury after a test the firm on DHA submitted as support contained considerably higher levels of the ingredient than included in the product.
The top-line data in the ultra-rare disease are also the first to demonstrate safety and efficacy of an RNAi therapy in patients six years and younger.